Embattled Canadian cannabis stocks have been climbing on the hope that the U.S. may ease restrictions on the substance. Staff work in a marijuana grow room that can be viewed by at the visitors centre at Canopy Growth's former facility in Smiths Falls, Ont. on Thursday, Aug. 23, 2018. THE CANADIAN PRESS/Sean Kilpatrick
TORONTO – Embattled Canadian cannabis stocks have been climbing on the hope that the U.S. may ease restrictions on the substance.
The Associated Press reported that the U.S. health department has recommended marijuana be moved from a schedule one to a schedule three controlled substance.
U.S. Senate leaders hailed the recommendation Wednesday as a first step toward easing federal restrictions on cannabis.
Shares in Canopy Growth Corp. were up almost 36 per cent around noon Thursday, after climbing nine per cent Wednesday.
Tilray Brands Inc. shares were up almost 12 per cent, after its stock rose more than 10 per cent Wednesday.
Shares of Aurora Cannabis Inc. were up almost eight per cent around noon on Thursday.
This report by The Canadian Press was first published Aug. 31, 2023.
Companies in this story: (TSX:TKTK)
